Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of OROS Methylphenidate in Adults With ADHD
NCT00714688Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of methylphenidate-OROS in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Pharmaceutical. Started Feb 2008; status: completed.
02
Drugs
methylphenidate-OROS
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00714688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00714688.